Aerin Medical
Mountain View, US · Founded 2011 · Delaware corporation · 148 employees on LinkedIn · 6 known investors
Aerin Medical develops non-invasive radiofrequency treatment systems for chronic nasal conditions, offering the VivAer stylus for nasal airway obstruction and RhinAer stylus for chronic rhinitis. The treatments are performed in doctor's offices and operating rooms using a touch-screen console that delivers temperature-controlled radiofrequency therapy.
Founders & leadership
MB

Matt BrokawCEO & President
DS
Derrick SungExecutive
MS

Matthew SalkeldExecutive
IR
Irina RidleyExecutive
AC
Andre ChengExecutive
FD
Fred DingerExecutive
SW

Scott WolfExecutive
Board
GG
Gregory GarfieldBoard director
KR
Kevin ReillyBoard director
KL
Karen LongBoard director
RD

NK
Nael KassarBoard director
Investors · 6
Reported raises · per SEC filings
Form D private placements$144.9M disclosed across 7 rounds · 2014–2024
▶$32.5MraisedDec 2024 · 23 investors · Other Health CareRule 506(b)
▶$32.5MraisedDec 2024 · 23 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Gregory GarfieldDirector
- Derrick SungExecutive Officer
- Matthew BrokawExecutive Officer, Director
- David ThrowerDirector
- Matthew SalkeldExecutive Officer
- Irina RidleyExecutive Officer
- Kevin ReillyDirector
- Andre ChengExecutive Officer
- Karen LongDirector
- William FacteauDirector
- Ryan DrantDirector
- Nael KassarDirector
- Scott WolfExecutive Officer
- Offering amount
- $32.8M
- Amount sold
- $32.5M
- First sale
- Dec 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$34.9MraisedMay 2022 · 2 investors · Other Health CareRule 506(b)
▶$34.9MraisedMay 2022 · 2 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Bill McClellanExecutive Officer
- John WhiteDirector
- Fred DingerExecutive Officer
- David ThrowerDirector
- William FacteauDirector
- Scott WolfExecutive Officer
- Matthew BrokawExecutive Officer, Director
- Ryan DrantDirector
- Kevin ReillyDirector
- Karen LongDirector
- Gregory GarfieldDirector
- Offering amount
- $60M
- Amount sold
- $34.9M
- First sale
- Apr 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$49.7MraisedAug 2020 · 15 investors · Other Health CareRule 506(b)
▶$49.7MraisedAug 2020 · 15 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Karen LongDirector
- William FacteauDirector
- Matthew BrokawExecutive Officer, Director
- Valeska SchroederDirector
- Scott WolfExecutive Officer, Director
- Fred DingerExecutive Officer
- Bill McClellanExecutive Officer
- David ThrowerDirector
- Offering amount
- $49.7M
- Amount sold
- $49.7M
- First sale
- Aug 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$10MraisedDec 2017 · 16 investors · Other Health CareRule 506(b)
▶$10MraisedDec 2017 · 16 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Gregory GarfieldDirector
- Fred DingerExecutive Officer, Director
- Valeska SchroederDirector
- Scott WolfExecutive Officer, Director
- Kern BhugraDirector
- Offering amount
- $15M
- Amount sold
- $10M
- Minimum investment
- $1
- First sale
- Dec 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$10.6MraisedMar 2016 · 3 investors · Other Health CareRule 506(b)
▶$10.6MraisedMar 2016 · 3 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Fred DingerExecutive Officer, Director
- Kern BhugraDirector
- Gregory S. YoungDirector
- Nael KassarDirector
- Peter SavasDirector
- Scott WolfExecutive Officer, Director
- Greg GarfieldDirector
- Offering amount
- $10.6M
- Amount sold
- $10.6M
- Minimum investment
- $1
- First sale
- Mar 2016
- Incorporated
- Corporation, Delaware, 2011
- Federal exemptions
- 06b
▶$6.7MraisedOct 2015 · 11 investors · Other Health CareRule 506(b)
▶$6.7MraisedOct 2015 · 11 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Gregory GarfieldDirector
- Greg YoungDirector
- Kern BhugraDirector
- Fred DingerExecutive Officer, Director
- Scott WolfExecutive Officer, Director
- Peter SavasDirector
- Offering amount
- $14.4M
- Amount sold
- $6.7M
- Minimum investment
- $1
- Sales commissions
- $7.9K
- Placement agents
- Braymen Lambert & Noel Securities, Ltd.
- First sale
- Jul 2015
- Incorporated
- Corporation, Delaware, 2011
- Federal exemptions
- 06b
▶$525KraisedFeb 2014 · 4 investors · Other Health CareRule 506(b)
▶$525KraisedFeb 2014 · 4 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Greg GarfieldDirector
- Kern BhugraDirector
- Scott WolfExecutive Officer, Director
- Offering amount
- $2.5M
- Amount sold
- $525K
- Minimum investment
- $1
- First sale
- Feb 2014
- Incorporated
- Corporation, Delaware, 2011
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 1
by search overlapCompanies competing with Aerin Medical for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Aerin Medical do?
- Aerin Medical develops non-invasive radiofrequency treatment systems for chronic nasal conditions, offering the VivAer stylus for nasal airway obstruction and RhinAer stylus for chronic rhinitis. The treatments are performed in doctor's offices and operating rooms using a touch-screen console that delivers temperature-controlled radiofrequency therapy.
- Who are Aerin Medical's investors?
- Aerin Medical's investors include LaunchCapital, OrbiMed, Questa Capital, Targeted Technology Funds, Ally Bridge Group, Horizon.
- How much funding has Aerin Medical raised?
- Aerin Medical has disclosed $144.9M raised across 7 rounds.
- Where is Aerin Medical headquartered?
- Aerin Medical is headquartered in Mountain View, US.


